Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
We are excited to announce that Viseven will be a Bronze Sponsor at Fierce Pharma Week 2026. Come find us at Booth #619 to learn how our content intelligence solutions are helping pharma companies drive measurable impact. Who You’ll Meet at Our Booth Panel Discussion Time: 1:15 PM – 1:45 PM Track: DTC & Patient […]
We are thrilled to announce that Viseven will be attending the Next Pharma Summit 2026. This huge industry event brings together pharma and life sciences leaders to explore the future of medical and commercial innovation — and Viseven will be right at the heart of the conversation, where we will talk about HCP engagement, content supply chain, and […]
Viseven will be attending Reuters Pharma Europe 2026, one of the leading cross-functional gatherings for pharmaceutical leaders, taking place on April 22–24 in Barcelona. This event brings together more than 1200 attendees, over 180 speakers, and senior leaders from across the top 50 pharma companies. Reuters Pharma EU reflects a shift happening across the industry: from isolated functions to connected, cross-functional collaboration. This […]
The Viseven team will travel to Philadelphia to attend the event we can’t afford to miss, Reuters Pharma USA. Reuters Pharma USA is recognized as North America’s largest cross-functional pharma gathering, and for good reason. It brings together more than 1,500 attendees and over 170 speakers from across the industry, including representatives from 100% of the Top 50 pharma companies. […]
We are excited to announce that Viseven will attend the New Dawn Summit in Berlin this year. Our CEO, Nataliya Andreychuk, will take a stage to talk about AI orchestration and its transforming impact on HCP engagement. Why join? And yes, coffee breaks are designed for meaningful connections. Don’t Miss Nataliya Andreychuk’s Speech At the New Dawn Summit, Nataliya Andreychuk, CEO and […]
The Viseven Team will be participating in the NEXT CX & AI Vienna, where leaders from across Europe will come together to discuss customer experience and AI, and how they are evolving in the pharmaceutical industry. This year, Viseven is the Silver Sponsor of the event, an honor that allows us to contribute to such an important occasion. At the event, you […]
The Viseven Team is headed to Pharma Customer Engagement USA 2025, one of the most anticipated events of the year in the pharma and life sciences industries. Viseven is a Gold Sponsor this year, and we are thrilled to be a part of such an important industry conference. During the event, you can find our […]
Global pharma companies appear to hold all the cards in emerging markets — stronger R&D pipelines, higher digital maturity, and the resources to execute at scale. Yet drug accessibility rarely comes down to a single decision at corporate HQ. Behind every market entry lies a more complex reality: localization is not simply translation, and most […]
In pharma, broken processes have a long shelf life. Content workflows are no exception — teams notice the inefficiencies, the duplicated effort, the review cycles that drag on for too long, but the perceived risk of changing anything keeps them from acting on it. The result is a kind of institutional inertia: everyone sees the […]
Would you be okay starting a therapy with a 2.5-star rating for a condition where every moment impacts clinical outcomes? Now imagine coming across a negative patient review, or seeing a trusted HCP publicly question its effectiveness or highlight side effects. Even in oncology, where treatment decisions are guided by HCPs, what patients read online […]
